Management of invasive meningococcal disease in children and young people: Summary of SIGN guidelines

BMJ

Volumn 336, Issue 7657, 2008, Pages 1367-1370

  Theilen, U ^a   Wilson, L ^b   Wilson, G ^c   Beattie, J O ^d   Qureshi, S ^e   Simpson, D ^a  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c ROYAL ABERDEEN CHILDREN S HOSPITAL   (United Kingdom)

^d ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^e Scottish Intercollegiate Guidelines Network   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; CEFOTAXIME; CEFTRIAXONE; CIPROFLOXACIN; CORTICOSTEROID; DEXAMETHASONE; HARTMANN SOLUTION; INFUSION FLUID; MENINGOCOCCUS VACCINE; MINOCYCLINE; RIFAMPICIN;

ALGORITHM; CHEMOPROPHYLAXIS; CHILD; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CLINICAL PRACTICE; DIAGNOSTIC APPROACH ROUTE; DISEASE TRANSMISSION; EARLY DIAGNOSIS; FLUID RESUSCITATION; HEALTH CARE; HOSPITAL CARE; HUMAN; IMMUNIZATION; INFECTION CONTROL; INTENSIVE CARE; MENINGOCOCCOSIS; MONOTHERAPY; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SHORT SURVEY; UNITED KINGDOM;

ADRENAL CORTEX HORMONES; ANTI-BACTERIAL AGENTS; CHILD; EARLY DIAGNOSIS; FLUID THERAPY; HOSPITALIZATION; HUMANS; INTENSIVE CARE; LONG-TERM CARE; MENINGOCOCCAL INFECTIONS; PRACTICE GUIDELINES AS TOPIC;

EID: 46249093167     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.a129     Document Type: Short Survey

References (11)

1. Health Protection Scotland. Surveillance systems: meningococcal invasive disease augmented surveillance (MIDAS). 2008. www.hps.scot.nhs.uk/ resp/ssdetail.aspx?id=13
2. Health Protection Agency. Enhanced surveillance of meningococcal disease national annual report: July 2002-June 2003. London: HPA, 2003.
3. Tibby SM, Murdoch IA, Durward A. Mortality in meningococcal disease: please report the figures accurately. Arch Dis Child 2002;87:559.
4. Carcillo JA, Fields AI. Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med 2002;30:1365-78.
5. Booy R, Habibi P, Nadel S, de Munter C, Britto J, Morrison A, et al. Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery. Arch Dis Child 2001;85:386-90.
6. Scottish Intercollegiate Guidelines Network. Management of invasive meningococcal disease in children and young people. Edinburgh: SIGN, 2008.
7. Thompson MJ, Ninis N, Perera R, Mayon-White R, Phillips C, Bailey L, et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet 2006;367:397-403.
8. Riordan F, Marzouk O, Thomson AP, Sills JA, Hart CA. The changing presentations of meningococcal disease. Eur J Pediatr 1995;154:472-4.
9. Health Protection Agency Meningococcus Forum. Guidance for public health management of meningococcal disease in the UK. London: Health Protection Agency, 2006. (Available from www.hpa.org.uk.)
10. Ninis N, Phillips C, Bailey L, Pollock JI, Simon N, Britto J, et al. The role of healthcare delivery in the outcome of meningococcal disease in children: case-control study of fatal and non-fatal cases. BMJ 2005;330:1475-8.
11. National Institute for Health and Clinical Excellence. Feverish illness: assessment and initial managementin children younger than 5 years. London: NICE, 2007. www.nice.org.uk/CG047.